AQHA Queen Quiz: Violations

A person responsible for the care of a horse is also responsible for and may be disciplined for the inhumane conduct of their trainers, agents, representatives, and employees.

1. Placing an object in a horse's mouth so as to cause undue discomfort or distress (minimum level [blank_start]2[blank_end]) 2. Leaving a bit in a horse's mouth for extended periods of time so as to cause under discomfort or distress (minimum level [blank_start]1[blank_end]) 3. Tying a horse's head up (above withers), back or around in a stall or anywhere at an AQHA event in a manner as to cause undue discomfort or distress (minimum level [blank_start]2[blank_end]) 4. Tying a horse in a stall without access to food or water for an extended period of time. (minimum level [blank_start]1[blank_end]) 5. Lounging or riding a horse in a manner as to cause undue discomfort or distress to the horse (minimum level [blank_start]1[blank_end]) 6. Tying or fastening any foreign object onto a horse, halter, bridle an/or saddle in order to de-sensitize the horse (minimum level [blank_start]2[blank_end]) 7. Use of training techniques or methods such as poling or striking a horse's legs with objects (minimum level [blank_start]2[blank_end]) 8. Excessive spurring or whipping (minimum level [blank_start]1[blank_end]) 9. Excessive fencing (minimum level [blank_start]1[blank_end]) 10. Excessive spinning (defined as no more than 8 consecutive turns in either direction) (minimum level [blank_start]1[blank_end]) 11. Schooling over ramped oxers in reverse order (minimum level [blank_start]1[blank_end]) 12. Schooling using rails higher than 4 feet (minimum level [blank_start]1[blank_end]) 13. Use of prohibited equipment (minimum level [blank_start]2[blank_end]) 14. Use of any item or appliance that restricts movement or circulation of the horse's tail (minimum level [blank_start]3[blank_end]) 15. Exhibiting a horse which appears to be sullen, dull, lethargic, emaciated, drawn, or overly tired (minimum level [blank_start]1[blank_end]) 16. Intentional or negligent treatment which results in any bleeding (minimum level [blank_start]3[blank_end]), unintentional (minimum level [blank_start]1[blank_end]) 17. Applying excessive pressure on or excessively jerking of a halter lead shank or an allowed lip chain (minimum level [blank_start]2[blank_end]) 18. Any other treatment or conduct deemed by a show official to be inhumane or abusive (minimum level [blank_start]1[blank_end])

3 ways to inhibit competition:

Select the 3 parties that are each responsible for a horse's condition, presumed to know all AQHA rules and regulations, and are eligible for disciplinary sanctions for violation of AQHA rules and regulations according to AQHA's disciplinary procedures

Absolutely Responsible Party:

The Responsible Party is eligible for disciplinary sanctions, whether or not they had actual knowledge of a prohibited medication, drug or substance, directly participated in the administration thereof, innocently miscalculated it's retention time in the horse's system, or any other reason for which its presence is established.

Exceptions to prohibited surgical procedure, mechanical device, or artificial appliance:

Normal tail function is described as "being able to raise the tail [blank_start]to or above the horizontal plane[blank_end]"

Forbidden drugs or substances include: 1. Any drug or substance considered a [blank_start]class 1[blank_end] or [blank_start]class 2[blank_end] substance as defined in the most recent edition of the American Racing Commissioners International [blank_start]Uniform[blank_end] Classification [blank_start]Guidelines[blank_end] for Foreign Substances 2. Any [blank_start]stimulant[blank_end], [blank_start]depressant[blank_end], [blank_start]tranquilizer[blank_end] or [blank_start]sedative[blank_end] which could affect the performance of a horse (stimulants and depressants are defined as substances that stimulate or depress the cardiovascular, [blank_start]respiratory[blank_end], or central nervous system) 3. Any substance, regardless of how [blank_start]harmless[blank_end] or [blank_start]innocuous[blank_end] it might be, that might interfere with the [blank_start]detection[blank_end] or quantification of any substance 4. Any [blank_start]anabolic[blank_end] steroid in [blank_start]halter[blank_end] classes 5. Any [blank_start]nonsteroidal[blank_end] anti-inflammatory drug (NSAID) other than those listed in conditionally permitted 6. Any [blank_start]metabolite[blank_end] and/or [blank_start]analog[blank_end] of the above described forbidden drugs or substances

BUTE - [blank_start]Phenylbutazone[blank_end]: This drug is a(n) [blank_start]NSAID[blank_end] Maximum permitted plasma concentration: [blank_start]15[blank_end].0 micrograms per millileter For a 1,000 lb animal, the maximum daily dose is: [blank_start]2[blank_end].0 grams or [blank_start]10[blank_end]cc of the injectable Neither a daily dose nor part of an injectable dose should be administered in the [blank_start]12[blank_end] hours prior to competing. If administered orally, [blank_start]half[blank_end] the maximum daily dose can be administered each 12 hours. Should not be used for more than [blank_start]5[blank_end] successive days.

Diclofenac (Surpass): Maximum permitted plasma concentration: 0.[blank_start]005[blank_end] microgram per millileter Every 12 hours, not more than [blank_start]73[blank_end]mg of dicloefenac liposomal cream should be administered to one site. Not more than [blank_start]146[blank_end]mg per 24 hour period. Should be discontinued [blank_start]12[blank_end] hours prior to competing. Should not be administered for more than [blank_start]10[blank_end] successive days.

Flunixin: A(n) [blank_start]NSAID[blank_end] Maximum permitted plasma concentration: [blank_start]1[blank_end].0 microgram per millileter. For a 1,000 animal, the maximum daily does is [blank_start]500[blank_end]mg, whether it be granules or oral paste. [blank_start]10[blank_end]cc of the injectable No part of the dose should be administered in the [blank_start]12[blank_end] hours prior to competing. Not to be used for more than [blank_start]5[blank_end] successive days.

Ketoprofen: A(n) [blank_start]NSAID[blank_end] Maximum permitted plasma concentration: [blank_start]40[blank_end].0 nanograms per milliliter For a 1,000 pound animal, the maximum daily dose is [blank_start]1[blank_end].0 gram(s). [blank_start]10[blank_end]cc of the injectable No part of the dose should be administered in the [blank_start]12[blank_end] hours prior to competing. Should not be used more than [blank_start]5[blank_end] successive days.

Meclofenamic Acid Also known as: [blank_start]Arquel[blank_end] and is a(n) [blank_start]NSAID[blank_end]. Maximum permitted plasma concentration: [blank_start]2.5[blank_end] micrograms per millileter. For a 1,000lb animal, the maximum 12 hour dose is 0.[blank_start]5[blank_end] gram(s) Should not be used for more than [blank_start]5[blank_end] successive days.

Naproxen: A(n) [blank_start]NSAID[blank_end] Maximum permitted plasma concentration: [blank_start]40[blank_end].0 micrograms per millileter For a 1,000 animal, maximum daily dose: [blank_start]4[blank_end].0 grams No part of the dose should be administered in the [blank_start]12[blank_end] hours prior to competing. Should not be used for more than [blank_start]5[blank_end] consecutive days.

Fibrocoxib (Equioxx): A(n) [blank_start]NSAID[blank_end] Maximum permitted plasma concentration: 0.[blank_start]240[blank_end] microgram per millileter For 1,000lb animal, maximum daily dose: [blank_start]45.5[blank_end] milligrams No part of the dose should be administered in the [blank_start]12[blank_end] hour prior to competition. Should not be administered for more than [blank_start]14[blank_end] consecutive days.

Eltenac: A(n) [blank_start]NSAID[blank_end] Pending [blank_start]FDA[blank_end] Approval. Maximum permitted plasma concentration: 0.[blank_start]1[blank_end] microgram per milliliter For 1,000 lb animal, maximum daily dose: [blank_start]250[blank_end] milligrams [blank_start]5[blank_end]cc of the injectable Should not be used for more than 5 consecutive days

Acetazolamide: May only be administered if horse is documented through DNA testing to be [blank_start]HYPP[blank_end] positive. For a 1,000 horse, maximum daily dose: 3 grams

Furosemide or Lasix: When used must be administered [blank_start]intravenously[blank_end] at least four hours prior to competition.

Isoxsuprine: For a 1,000lb animal, maximum daily dose: [blank_start]1600[blank_end] milligrams No part of a dose should be administered in the [blank_start]4[blank_end] hours prior to competing.

Lidocaine/Mepivicaine: May only be used under actual observation of [blank_start]event[blank_end] management and/or the official show [blank_start]veterinarian[blank_end]. [blank_start]Medication[blank_end] report form must be filed with [blank_start]show[blank_end] management.

Dexamethasone: Maximum permitted plasma concentration: [blank_start]3[blank_end].0 nanograms per milliter. Should not be administered for more than [blank_start]5[blank_end] successive days.

Any member may be suspended and denied AQHA privileges and any nonmember may be denied AQHA privileges by AQHA's Executive Vice President for:

Maximum fine for enhancement of penalty

Check which associations have reciprocity with AQHA